However, in the present work we found a strong mGluR5 upregulation in MS lesion-associated astrocytes (Fig. 5D–E), similar to a study that reported GFAP+ astrocytes within human MS lesions upregulate mGluR5 protein as defined by immunohistochemistry [37]. This evidence concerns the gene GRM5 and myeloid sarcoma.